SÜSS MicroTec SE (SMHN)
XETRA Stock Exchange · Germany · prices in EUR · close of 19 Oct 2026
Key indicators
| Last close | EUR 55.80 |
|---|---|
| 52-week range | 25.79 – 118.40 |
| Return, 1 month / 3 months | −18.0% / −33.7% |
| Return, 1 year / 3 years | +55.1% / +197.1% |
| Trend | Below its 200-day average |
| RSI (14) | 29 |
| Volatility (1 year) | 72.9% |
| Worst drawdown (1 year) | -50.0% |
| Average daily value traded | 6.80M EUR |
| Dividend yield | 0.1% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
SÜSS MicroTec SE designs and builds equipment used to manufacture semiconductors and microsystems. Its product lines include mask aligners and other lithography tools, coating and developing systems, and wafer bonding and inspection equipment. Customers are chipmakers, research institutes and microelectronics manufacturers working in areas such as microelectromechanical systems, advanced packaging and compound semiconductors. The company is based in Garching near Munich, Germany, and supplies customers in Europe, Asia and North America.
On this site SÜSS MicroTec SE appears as a stock on the XETRA Stock Exchange (Germany), code SMHN, with prices in euros (EUR). Our dividend records, which start in 2019, show payments in 5 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
SÜSS MicroTec SE (SMHN) trades on the XETRA Stock Exchange in Germany. It last closed at EUR 55.80 on 19 October 2026.
Its price-based Market X-Ray is 36 out of 100 (a weak price profile), ranking 524 of 701 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 55.1% and over the last three months it fell 33.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on XETRA Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 26 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -20.3% | ||
| From 52-week high | -50.0% | ||
| Momentum | 41 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -33.7% | ||
| 6-month return | -19.5% | ||
| 12-month return, skipping the last month | 89.2% | ||
| Risk (lower is better) | 13 · Weak | Volatile, with deep drawdowns. | |
| Volatility (1 year) | 72.9% | ||
| Worst drawdown (1 year) | -50.0% | ||
| Liquidity | 88 · Strong | Trades actively. | |
| Average daily value traded | 6.80M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 24 · Weak | Dividend is small or irregular. | |
| Dividend yield | 0.1% | ||
| Years with dividends | 5 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Risk (lower is better): Volatile, with deep drawdowns.
- Income: Dividend is small or irregular.
Returns
| 1 week | −12.8% |
|---|---|
| 1 month | −18.0% |
| 3 months | −33.7% |
| 6 months | −19.5% |
| 1 year | +55.1% |
| 3 years | +197.1% |
| 5 years | +128.9% |
Signals
| 50-day / 200-day average | 70.43 / 70.05 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 3.47 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 4 Jun 2026 | EUR 0.0400 |
| 4 Jun 2025 | EUR 0.3000 |
| 12 Jun 2024 | EUR 0.2000 |
| 1 Jun 2023 | EUR 0.2000 |
| 1 Jun 2022 | EUR 0.1600 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on XETRA Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.